Tolerance of Infants Fed a Hydrolyzed Rice Infant Formula with 2′-Fucosyllactose (2′-FL) Human Milk Oligosaccharide (HMO)
Nutrients · 13.06.2024 · 16 (12) · 1863
DOI: 10.3390/nu16121863 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Nutrients, online erschienen am 13.06.2024. Verfasst von Carlett Ramirez-Farias und 3 weiteren Autor:innen. Beteiligte Einrichtung: Scientific & Medical Affairs, Abbott Nutrition, Columbus, OH 43219, USA. Hauptthemen laut MEDLINE: Infant Formula, Trisaccharides, Milk, Human, Oryza. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott Nutrition, Abbott Nutrition, Abbott Laboratories.
Abstract (Originalsprache)
Background
The purpose of this research was to assess the growth, tolerance, and compliance outcomes associated with the consumption of a hydrolyzed rice infant formula (HRF) enriched with 2′-Fucosyllactose (2′-FL) a Human Milk Oligosaccharide (HMO), and nucleotides in an intended population of infants.
Methods
This was a non-randomized single-group, multicenter study. The study formula was a hypoallergenic HRF with 2′-FL, Docosahexaenoic acid (DHA), Arachidonic acid (ARA), and nucleotides. Infants 0–90 days of age who were formula fed and experiencing persistent feeding intolerance symptoms, symptoms of suspected food protein (milk and/or soy) allergy, or other conditions where an extensively hydrolyzed infant formula was deemed an appropriate feeding option were recruited by pediatricians from their local populations. The primary outcome was maintenance of weight-for-age z-score. Weight, length, head circumference, formula intake, tolerance measures, clinical symptoms and questionnaires were collected. Thirty-three infants were enrolled, and 27 completed the study, on study product.
Results
Weight-for-age z-scores of infants showed a statistically significant improvement from Visit 1 to Visit 4 (p = 0.0331). There was an adequate daily volume intake of 762 ± 28 mL/day, average daily number of stools of 2.1 ± 0.3, and mean rank stool consistency of 2.38 ± 0.18. After 28 days of switching to a HRF, 86.8 ± 5.9% of the symptoms resolved or got better by Visit 4 as reported by parents.
Conclusions
HRF with 2′-FL HMO was safe, well tolerated, and supported weight gain in infants with suspected cow’s milk allergy or persistent feeding intolerance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Scientific & Medical Affairs, Abbott Nutrition, Columbus, OH 43219, USA.
ORCID-Profile: Carlett Ramirez-Farias
Förderung
- Abbott Nutrition
- Abbott Nutrition, Abbott Laboratories
Zitieren
APA
Ramirez-Farias, C., Oliver, J. S., Schlezinger, J., & Stutts, J. T. (2024). Tolerance of Infants Fed a Hydrolyzed Rice Infant Formula with 2′-Fucosyllactose (2′-FL) Human Milk Oligosaccharide (HMO). Nutrients, 16(12), 1863. https://doi.org/10.3390/nu16121863
Vancouver
Ramirez-Farias C, Oliver JS, Schlezinger J, Stutts JT. Tolerance of Infants Fed a Hydrolyzed Rice Infant Formula with 2′-Fucosyllactose (2′-FL) Human Milk Oligosaccharide (HMO). Nutrients. 2024;16(12):1863. doi:10.3390/nu16121863
BibTeX
@article{RamirezFarias2024,
author = {Ramirez-Farias, Carlett and Oliver, Jeffery S and Schlezinger, Jane and Stutts, John T},
title = {Tolerance of Infants Fed a Hydrolyzed Rice Infant Formula with 2′-Fucosyllactose (2′-FL) Human Milk Oligosaccharide (HMO)},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {12},
pages = {1863},
doi = {10.3390/nu16121863}
}
EUVIMED